"REFILL" | Peter Pitt on FDA Advisory Committees, Make America Healthy Again, and Drug Pricing (Originally Aired: May 23, 2025)

Joe Grogan sits down with Peter Pitt, FDA veteran and expert on healthcare regulation, to discuss FDA advisory committees, the Make America Healthy Again initiative, and critical gaps in pharmaceutical labeling. Pitt addresses why obesity-related drug dosing information is missing from labels, the importance of vaccine safety, food regulation reform, and strategies for lowering drug prices through generic drug reviews and supply chain diversification. He also discusses the need for FDA and CMS to work together and warns against mission creep at CMS.Key Timestamps0:44 Background: East Coast native, McGill University, from New York City1:07 How he got a professorship at University of Paris School of Medicine2:35 Mark McClellan connection and FDA career start5:19 Conflicts of interest versus interests in FDA advisory committees7:07 Why people need to be dismissed from advisory committees9:13 Three basic reasons FDA holds advisory committee meetings11:08 Why Canada keeps advisory committees secret versus FDA transparency14:08 Advisory committees for CYA, new science, and lack of consensus19:44 Op-ed on vaccines and nutrition under Make America Healthy Again22:44 Cancer drug dosing for obese patients and missing label information27:15 Learning about drug dosing outside of clinical trials30:42 Food regulation and FDA's second-class treatment of food safety32:02 MAHA moment and removing red food dyes from food supply34:00 Dietary supplements regulation under DSHEA35:21 Nutrition labeling updates and soda bottle serving sizes38:21 PDUFA reauthorization and user fees40:32 User fees about predictability not speed42:54 CMS mission creep and encroaching on FDA authorityKey TopicsFDA advisory committees, transparency, vaccine safety, Make America Healthy Again, pharmaceutical labeling, obesity and drug dosing, food regulation, dietary supplements, generic drug review, PDUFA reauthorization, user fees, CMS mission creep, drug pricingAbout the Guest (at time of recording, May 2025)Peter Pitt is President and Co-Founder of the Center for Medicine in the Public Interest and a visiting professor at the University of Paris School of Medicine. He is a former associate commissioner at the FDA where he oversaw advisory committees and served as a senior policy and communications advisor. Pitt is a native of New York City, a McGill University graduate, and speaks fluent French.Podcast: DC EKG with Joe GroganHost: Joe GroganGuest: Peter PittSponsor: Survivors for SolutionsExecutive Producer: John CZ Czwartacki, DC EKG Podcast